Abstract
Adult stem cell-derived smooth muscle cells (SMC) may be a promising source of cells for applications in regenerative medicine, including cardiovascular tissue engineering. Primary SMC from native vessels may have limited proliferative capacity and reduced collagen production when sourced from elderly donors, who are the patients in need of vascular grafts due to coronary disease or peripheral arterial disease. Our recent work showed that the ability of human bone marrow-derived mesenchymal stem cells (hMSCs) to differentiate into SMC was modulated by various growth factors, matrix proteins, and mechanical forces. In addition, the components of the culture medium play a very important role in SMC differentiation from hMSCs. In this chapter, we will summarize our experience with the impact of various factors on SMC differentiation from hMSCs. Based upon our findings regarding growth factors, cyclic strain and matrix proteins, a two-phase vessel regeneration culture protocol including a 4-week proliferation phase and a 4-week differentiation phase was developed to optimize proliferation and SMC differentiation of hMSCs consecutively.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaushal, S., Amiel, G.E., Guleserian, K.J., Sharpira, O.M., Perry, T., Sutherland, F.W., Rabkin, E., Moran, A.M., Schoen, F.J., Atala, A., Soker, S., Bischoff, J., and Mayer, J.E. (2001) Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7, 1035–1040.
Kadner, A., Heorstrup, S.P., Zund, G., Eid, K., Maurus, C., Melinitchouk, S., Grunenfelder, J., and Turina, M.I. (2002) A new source for cardiovascular tissue engineering: Human bone marrow stromal cells. Eur. J. Cardiothorac. Surg. 21, 1055–1060.
Hoerstrup, S.P., Kadner, A., Melnitchouk, S., Trojan, A., Eid, K., Tracy, J., Sodian, R., Visjager, J.F., Kolb, S.A., Grunenfelder, J., Zund, G., and Turina, M.I. (2002) Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106, I143–I150.
Perry, T.E., Kaushal, S., Sutherland, F.W., Guleserian, K.J., Bischoff, J., Sacks, M., and Mayer, J.E. (2003) Bone marrow as a cell source for tissue engineering heart valves. Ann. Thorac. Surg. 75, 761–767.
Matsumura, G., Miyagawa-Tomita, S., Shin’oka, T., Ikada, Y., and Kurosawa, H. (2003) First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108, 1729–1734.
Wu, X., Rabkin-Aikawa, E., Guleserian, K.J., Perry, T.E., Masuda, Y., Sutherland, F.W., Schoen, F.J., Mayer, J.E., and Bischoff, J. (2004) Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 287, H480–H487.
Cho, S.W., Lim, S.H., Kim, I.K., Hong, Y.S., Kim, S.S., Yoo, K.J., Park, H.Y., Jang, Y., Cahng, B.C., Choi, C.Y., Hwang, K.C., and Kim, B.S. (2005) Small-diameter blood vessels engineered with bone marrow-derived cells. Ann. Surg. 241, 506–515.
Liu, J.Y., Swartz, D.D., Peng, H.F., Gugino, S.F., Russell, J.A., and Andreadis, S.T. (2007) Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc. Res. 75, 618–628.
Gong, Z., Calkins, G., Cheng, E., Krause, D., and Niklason, L.E. (2009) Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells. Tissue Eng. Part A 15, 319–330.
Zhang, F., Tsai, S., Kato, K., Yamanouchi, D., Wang, C., Rafii, S., Liu, B., and Kent, K.C. (2009) Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J. Biol. Chem. 284, 17564–17574.
Kobayashi, N., Yasu, T., Ueba, H., Sata, M., Hashimoto, S., Kuroki, M., Saito, M., and Kawakami, M. (2004) Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp. Hematol. 32, 1238–1245.
Ball, S.G., Shuttleworth, A.C., and Kielty, C.M. (2004) Direct cell contact influences bone marrow mesenchymal stem cell fate. Int. J. Biochem. Cell Biol. 36, 714–727.
Lozito, T.P., Kuo, C.K., Taboas, J.M., and Tuan, R.S. (2009) Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J. Cell Biochem. 107, 714–722.
Gong, Z., and Niklason, L.E. (2008) Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 22, 1635–1648.
Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., and Langer, R. (1999) Functional arteries grown in vitro. Science 284, 489–493.
Niklason, L.E., Abbott, W., Gao, J., Klagges, B., Hirschi, K.K., Ulubayram, K., Conroy, N., Jones, R., Vasanawala, A., Sanzgiri, S., and Langer, R.L. (2001) Morphologic and mechanical characteristics of bovine engineered arteries. J. Vasc. Surg. 33, 628–638.
Acknowledgments
The authors are grateful for Drs. Caroline Rhim and Shannon L. M. Dahl for their contribution to the development and optimization of the bioreactor setup protocol. This work is funded by National Institute of Health RO1HL083895 and HL063766 (both to LEN).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Disclosure
Disclosure
L.E.N. has a financial interest in Humacyte, Inc., a regenerative medicine company. Humacyte did not fund these studies, and Humacyte did not affect the design, interpretation, or reporting of any of the experiments herein.
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gong, Z., Niklason, L.E. (2011). Use of Human Mesenchymal Stem Cells as Alternative Source of Smooth Muscle Cells in Vessel Engineering. In: Vemuri, M., Chase, L., Rao, M. (eds) Mesenchymal Stem Cell Assays and Applications. Methods in Molecular Biology, vol 698. Humana Press. https://doi.org/10.1007/978-1-60761-999-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-60761-999-4_21
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-998-7
Online ISBN: 978-1-60761-999-4
eBook Packages: Springer Protocols